Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1A | P08908 | 7/20 | 0.44 |
| ▸ | DRD2 | P14416 | 7/20 | 0.44 |
| ▸ | DRD4 | P21917 | 7/20 | 0.44 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.44 |
| ▸ | CHRNA7 | P36544 | 2/20 | 0.42 |
| ▸ | CNR2 | P34972 | 1/20 | 0.42 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.42 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.42 |
| ▸ | IRAK4 | Q9NWZ3 | 5/20 | 0.37 |
| ▸ | PDE8A | O60658 | 1/20 | 0.36 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.34 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.34 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.34 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.34 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2609309 | 0.88 | CHRNA7 (0.46) | HTR1ADRD2DRD4KCNH2CHRNA7 | |
| SCHEMBL27362243 | 0.81 | HTR1A (0.41) | HTR1ADRD2DRD4KCNH2CHRNA7 | |
| SCHEMBL23103361 | 0.80 | TLR9 (0.42) | CHRNA7 | |
| SCHEMBL17896353 | 0.79 | HTR1A (0.40) | HTR1ADRD2DRD4KCNH2CHRNA7 | |
| SCHEMBL27266356 | 0.78 | HTR1A (0.41) | HTR1ADRD2DRD4KCNH2CHRNA7 | |
| SCHEMBL30730035 | 0.78 | HTR1A (0.46) | HTR1ADRD2DRD4KCNH2CHRNA7 | |
| SCHEMBL27314534 | 0.78 | HTR1A (0.37) | HTR1ADRD2DRD4KCNH2CHRNA7 | |
| SCHEMBL12093289 | 0.77 | DRD2 (0.53) | HTR1ADRD2DRD4KCNH2CHRNA7 | |
| SCHEMBL22211172 | 0.77 | CHRNA7 (0.38) | HTR1ADRD2DRD4KCNH2CHRNA7 | |
| SCHEMBL30730146 | 0.77 | HTR1A (0.45) | HTR1ADRD2DRD4KCNH2CHRNA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024026484-A2 | CDK2 INHIBITORS AND METHODS OF USING THE SAME | CEDILLA THERAPEUTICS, INC. (US) | 2024-02-01 | — | — | WO | disclosed |
| WO-2021030556-A1 | MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2021-02-18 | — | — | WO | disclosed |